# A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

> **NCT05579249** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 500 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Orlistat
- **DRUG:** Phentermine/Topiramate
- **DRUG:** Naltrexone/Bupropion
- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT05579249
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-19
- **Primary completion:** 2024-11-27
- **Final completion:** 2024-11-27
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05579249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05579249, "A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05579249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*